Mainz Biomed B.v. buy Marianka
Start price
31.01.22
/
80%
€13.86
Target price
31.01.23
€42.00
Performance (%)
-9.96%
End price
05.02.22
€12.48
Summary
This prediction ended on 05.02.22 with a price of €12.48. With a performance of -9.96%, the BUY prediction for Mainz Biomed B.v. by Marianka closed slightly in the red. Marianka has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mainz Biomed B.v. | -6.621% | -6.621% | -93.003% |
| iShares Core DAX® | 2.275% | 4.627% | 18.839% |
| iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% |
| iShares Nikkei 225® | 4.456% | 3.598% | 12.437% |
| iShares S&P 500 | 4.061% | 2.876% | 23.447% |
According to Marianka what are the pros and cons of Mainz Biomed B.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Fair valuation
Good rating
High Investments for future growth
Very valuable balance sheet
Very capable Management
Very good company culture
Leading role in innovation
Strong uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is very important
Stable Large shareholder and/or long term investor
Known brand
Future proof or reliable business model
Cons
Low dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Higher risks for its business
Below average Marketposition
Very high cyclical dependencies